These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients. Ni Z, Lu R, Xu X, Bian X, Zhou Z, Yang J, Luo Q, Chen M, Chen C, Sun X, Yu L, He Q, Jiang H, Yuan W, Li Y, Zhou R, Wang J, Zhang X, Zuo L, Meng X, Chang Z, Zhao J, Wessman P, Xiang P, DIALIZE China Study Group. Clin Ther; 2023 Jul; 45(7):633-642. PubMed ID: 37385905 [Abstract] [Full Text] [Related]
6. Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis. Zhang Y, Xu R, Wang F, Liu Y, Xu J, Zhao N, Cheng F, Long L, Jia J, Lin S. Cardiovasc Drugs Ther; 2021 Oct; 35(5):1057-1066. PubMed ID: 33459923 [Abstract] [Full Text] [Related]
7. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, Roger SD, Yang A, Lerma E, Singh B. JAMA; 2014 Dec 03; 312(21):2223-33. PubMed ID: 25402495 [Abstract] [Full Text] [Related]
8. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. BMC Nephrol; 2022 Feb 08; 23(1):59. PubMed ID: 35135481 [Abstract] [Full Text] [Related]
15. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE. Roger SD, Spinowitz BS, Lerma EV, Singh B, Packham DK, Al-Shurbaji A, Kosiborod M. Am J Nephrol; 2019 Jun 07; 50(6):473-480. PubMed ID: 31658466 [Abstract] [Full Text] [Related]
16. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia. Takkar C, Nassar T, Qunibi W. Expert Opin Pharmacother; 2021 Jan 07; 22(1):19-28. PubMed ID: 32892634 [Abstract] [Full Text] [Related]
17. Sodium zirconium cyclosilicate in hyperkalemia. Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B. N Engl J Med; 2015 Jan 15; 372(3):222-31. PubMed ID: 25415807 [Abstract] [Full Text] [Related]